MetLife (MET)
(Delayed Data from NYSE)
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.79 USD
+0.01 (0.01%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $81.78 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth C Momentum B VGM
Zacks News
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife's Rising Revenues & Streamlining Measures Aid Growth
by Zacks Equity Research
MetLife (MET) benefits from business streamlining, strong capital position and revenue growth.
Aflac Rides on Strong U.S. Business and Solid Balance Sheet
by Zacks Equity Research
Aflac's (AFL) favorable U.S business, changes in Japan business and a strong balance sheet are likely to aid its long-term growth.
MetLife (MET) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter earnings benefit from lower expenses, partly offset by decline in revenues.
MetLife (MET) Tops Q2 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 5.34% and -0.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Insurers Reporting Q2 Earnings on Jul 31: PRU, MET, WLTW, LNC
by Tanuka De
Insurers' Q2 earnings are likely to benefit from benign catastrophe environment, improved pricing and reinsurance agreements.
MetLife (MET) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
MetLife's (MET) Q2 earnings should benefit from increased contributions across its segments, partially offset by catastrophe losses.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This is Why MetLife (MET) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) to Sell Hong Kong Unit to Streamline Business
by Zacks Equity Research
MetLife (MET) to divest its Hong Kong unit to FWD Insurance for focusing on its profitable businesses.
Here's Why You Should Retain MetLife (MET) in Your Portfolio
by Zacks Equity Research
Solid underwriting revenues, strong balance sheet and superior operating profitability poise MetLife (MET) for growth.
CNO Financial Ratings Revised by S&P & Fitch, Outlook Stable
by Zacks Equity Research
CNO Financial (CNO) gets rated by S&P and Fitch, reflecting its reduced risk profile, balance sheet strength and operating measures.
Zacks.com featured highlights include: Hibbett Sports, Universal Forest, Citizens Financial, Westlake and Metlife
by Zacks Equity Research
Zacks.com featured highlights include: Hibbett Sports, Universal Forest, Citizens Financial, Westlake and Metlife
Pick These 7 Low Price-to-Sales Stocks for Optimum Returns
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
MetLife Looks to Utilize Blockchain
by Mitchell Moore
MetLife(MET), the largest player in a $2.7 trillion life insurance industry, recently announced a trial run of a completely revamped claims process. Blockchain, the technology underpinning cryptocurrency, will be utilized by MetLife in this significant procedural change.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Why Adding MetLife (MET) to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on a strong revenue base and solid business realignment measures, MetLife (MET) holds great potential to reap benefits for investors.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for June 14th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 14th
MGIC Investment's (MTG) May Insurance in Force Impressive
by Zacks Equity Research
MGIC Investment's (MTG) insurance in force was $213.3 billion, up 7% year over year.
MET or AIG: Which Multi-Line Insurer Looks More Attractive?
by Zacks Equity Research
Here we take a look at whether MET or AIG is better poised in the multi-line insurance industry, which is benefiting from rate increase, business diversification and product innovation.
Should Value Investors Consider MetLife (MET) Stock Now?
by Zacks Equity Research
Let's see if MetLife, Inc. (MET) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Why MetLife (MET) Could Be a Top Value Stock Pick
by Zacks Equity Research
MetLife (MET) seems to be a good value pick, as it has impressive value metrics, and is seeing solid earnings estimate revisions as well.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Down 0.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.